logo
The taboo colon cancer symptom millennials are afraid to tell their doctors about

The taboo colon cancer symptom millennials are afraid to tell their doctors about

When Sarah Beran started noticing blood in her poop, she didn't know how to bring it up to her doctor.
"I felt like I went in there with my tail between my legs, and not only was I talking about poop, but I was talking about my butt and blood and it's just all these things you don't want to talk about," Beran, 39, told Business Insider.
Beran, who was later diagnosed with stage 3 colon cancer at age 34, went on to talk about bowel movements a lot: she co-founded Worldclass, an apparel brand that donates proceeds to fund colonoscopies for people who are underinsured.
Beran's experience of anal bleeding is not uncommon. It is statistically the most common warning sign of colon cancer in patients under 50. Studies show that many patients, like Beran, feel embarrassed to talk about it with anyone, including their doctors.
More young people are being diagnosed with colon cancer. Part of why it's so difficult to diagnose is that early symptoms like diarrhea and bloating can be caused by everything from hemorrhoids to a gluten allergy. The other hurdle is stigma: people just don't want to talk about seeing blood in the toilet or in their pencil-thin stools.
"Unfortunately, it's something that I see quite frequently," Dr. Fola May, a gastroenterologist and an associate professor of Medicine at UCLA, told BI.
She said it's common for people to ignore and they may avoid sharing their symptoms out of embarrassment. "They delay bringing it up until it gets more and more severe, and they actually can't function or have a normal workday," May added.
By then, their cancer is likely to have progressed to later stages.
Anal bleeding is common with younger patients
Early colon cancer symptoms are easy to miss. Abdominal pain or constipation can be linked to many different conditions, like celiac disease or IBS. That's why rectal bleeding is important to flag.
Joshua Demb, a researcher who studies early-onset colon cancer and an assistant professor at the University of California, San Diego, led a 2024 study on the most common symptoms of colon cancer in young people.
Demb's study found rectal bleeding was the most common sign of colon cancer — more than altered bowel movements or abdominal pain — because it was more specific and harder to explain with lifestyle changes.
It can be hard to know how seriously to take some symptoms. Anal bleeding is often caused by non-life threatening conditions like hemorrhoids. Some patients who are otherwise young, healthy, and who have no family history can be dismissed by doctors, partly because colonoscopies are more involved procedures and can cost a few thousand dollars without insurance.
The difficult work is making sure a symptom is "attributed to the correct condition," Demb said, without preemptively scaring people or overlooking the early signs of colorectal cancer.
Millennials are afraid to talk about stool
Poop has a long history of being taboo, regarded as unsanitary and embarrassing. As societies like Victorian-era England developed indoor plumbing and individual latrines to replace communal ones, defecation became more private — and consequently more shameful to talk about in public.
The stigma has never really gone away.
From interviewing colon cancer patients, Demb learned many young people are afraid to broach the topic of poop and rectal bleeding with their doctor, even though that conversation could be life-saving.
"Part of that apprehension comes from probably not having had to discuss this ever before in their care," he said.
As people enter their 50s and colonoscopies become standard care, talking about bowel movements becomes slightly more normalized.
When Naiké Vorbe started cycling through diarrhea and constipation, she didn't know how to talk about it, and hesitated at first. "You don't really speak about gastrointestinal issues," Vorbe, who grew up in Haiti, told BI.
Vorbe was diagnosed with stage 3B colon cancer at 31. By then, her cancer had spread so much that she needed to have parts of her colon and liver removed.
Chris Rodriguez, who was otherwise fit and healthy when he was diagnosed with stage 3 rectal cancer at 35, remembers feeling embarrassed about sharing his digestive agony with friends, relatives, and even doctors.
He feels from personal experience that younger people are averse to talking about cancer because they feel they're "not supposed to" be worrying about it yet.
"I know that people are too afraid to talk about these things with their doctor, too afraid to talk about these things with anybody around them," Rodriguez, now 37, told BI. "That's pretty scary for me."
Vorbe and Rodriguez both had late-stage cancer and rectal bleeding as a symptom. It makes the symptom all the more important to flag: sometimes, blood in the stool won't show up until the cancer has progressed.
The push to make rectal bleeding less taboo
Brooks Bell, one of the Worldclass co-founders, remembers struggling to share how she was feeling with her husband — they weren't the types to use the bathroom with the door open, for instance.
"Every relationship is different," Bell, 44, said. "Our relationship did not have those features, and so it can be so awkward."
Now, she and Beran are trying to help younger people feel emboldened to talk about colon cancer symptoms and taboo body parts. Their brand, Worldclass, sells merch that says "Ass" and "Colonoscopy Enthusiast."
Bell also founded Lead From Behind, a campaign backed by the Colorectal Cancer Alliance that involved Ryan Reynolds and Rob McElhenney getting colonoscopies on camera to normalize the procedure.
But ultimately, the biggest change might have to start in the doctor's office. Even though she's a GI doctor, May said she still gets patients who blush when they talk about their bowel movements.
May says she tries to shift that dynamic by being intentional about her language. "When I'm in public, I say words like 'rectum' and 'poop' and 'stool,'" she said, adding that she wants her peers to do the same.
Talking about blood in poop should be as normalized as talking about spotting breast cancer lumps, May said. "Until we make them normal in public," she continued, "people will feel uncomfortable producing those words from their mouths."
How to know if you have a colon cancer symptom, or if it's something else
Because early colon cancer symptoms can be so ambiguous, Demb said the more important thing to look out for is deviation from your lifestyle.
For example, if you normally have very consistent bowel movements and suddenly have persistent diarrhea, see a GI. If you have ongoing rectal bleeding for the first time in your life or unusual stomach pain that won't go away, consider booking a colonoscopy.
May also suggested getting a colonoscopy sooner if you have any family history of the cancer. She recommended getting screened at age 40 instead of the standard 45, and for primary care physicians to start bringing up the potential of screening before age 45 in general.
Because colonoscopies can be expensive and inaccessible to people under 45, the best anyone can do is be vigilant, Demb said of symptoms like anal bleeding.
Rodriguez, who is now cancer-free, believes it's important to investigate any warning signs. "You're not being silly by thinking about them," he said. "You're not overreacting by thinking it could be cancer."
Additional reporting by Kim Schewitz and Mia de Graaf.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Warren Buffett's Berkshire Hathaway Buys Over 5 Million Shares in UnitedHealth Group (UNH)
Warren Buffett's Berkshire Hathaway Buys Over 5 Million Shares in UnitedHealth Group (UNH)

Yahoo

time2 hours ago

  • Yahoo

Warren Buffett's Berkshire Hathaway Buys Over 5 Million Shares in UnitedHealth Group (UNH)

UnitedHealth Group Incorporated (NYSE:UNH) is one of the most buzzing stocks to invest in right now. CNBC reported on August 14 that Warren Buffett's Berkshire Hathaway bought more than 5 million shares in UnitedHealth Group Incorporated (NYSE:UNH) last quarter, coming up to a stake worth around $1.6 billion. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated's (NYSE:UNH) shares soared after Buffett's latest quarterly filing was revealed, marking a 'surprising buy' due to the healthcare company's present reputation. According to VerityData, the stake purchase positions it as the 18th-biggest position in the Berkshire portfolio, standing behind Amazon and Constellation Brands. UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Little Mix's Jade Thirlwall says she faces a 'daily battle' not to go on Ozempic
Little Mix's Jade Thirlwall says she faces a 'daily battle' not to go on Ozempic

Business Insider

time13 hours ago

  • Business Insider

Little Mix's Jade Thirlwall says she faces a 'daily battle' not to go on Ozempic

Little Mix 's Jade Thirlwall says she is resisting Ozempic despite the public scrutiny around her body. In an interview with The Guardian published Saturday, the singer said that many of the negative comments she receives are about weight gain. "I have a daily battle with myself not to go on Ozempic," Thirlwall told The Guardian. "I don't judge people that do, but because I have a history of eating disorders, I don't know where taking something like that would end for me." Thirlwall said she had only been out of the hospital for a few months after treatment for anorexia when she auditioned for " The X Factor" in 2011 at 18. "Historically, if I've ever felt that something is out of my control, then restricting food has been a means of controlling my life in a very toxic way," she said. Little Mix was formed on "The X Factor" in 2011, comprising Thirlwall, Leigh-Anne Pinnock, Perrie Edwards, and Jesy Nelson. Nelson left the group in 2020 amid backlash over Blackfishing, and in 2022, the band went on hiatus to focus on their solo careers. Thirlwall said that much of the scrutiny around her body comes from people comparing her to her younger self. "Now I'm in my 30s and the healthiest I've ever been, but every time I post a picture, there are comments saying, 'She must be pregnant.' The sad thing is that it's usually women," Thirlwall said. "But people are used to seeing me in a group environment five or 10 years ago when I was stick-thin because I was in my early 20s with an eating disorder," she said. A representative for Thirlwall did not immediately respond to a request for comment sent by Business Insider outside regular hours. Ozempic and Wegovy are brand names for semaglutide, an injectable drug originally developed for diabetes. In 2021, the FDA approved semaglutide for use in weight management. The drug works by regulating hunger signals, allowing people to feel full while eating less. However, it has side effects such as nausea, diarrhea, and constipation. Some patients also reported feeling disgusted by the foods they used to enjoy. Dr. Francesco Rubino, the chair of metabolic and bariatric surgery at King's College London, told Business Insider in 2022 that it was common for people to regain the weight after stopping treatment. Several doctors also told Business Insider in July that they've seen a sharp increase in patients on GLP-1 medications when they enter treatment for eating disorders. In recent years, many Hollywood celebrities have addressed speculation about whether they've used weight-loss drugs. In May 2023, NBA star Charles Barkley said he lost over 60 pounds in six months after taking Mounjaro while eating healthily and exercising. Later that year, in December 2023, Oprah Winfrey said she uses weight-loss medication to help manage her weight. Meanwhile, stars such as Lizzo, Kelly Clarkson, and Jesse Plemons, have denied using such medications, attributing their weight loss instead to lifestyle changes.

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock
Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

Yahoo

time2 days ago

  • Yahoo

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On August 7, Mizuho analyst Ann Hynes kept her 'Buy' rating, expecting long-term value despite reducing the price objective to $300. The analyst noted that the company has reinstated its 2025 earnings guidance. The analyst believes that pricing pressure and increased medical cost trends will continue into 2026. Furthermore, the analyst also highlighted the underperformance in Optum Health's value-based care and Optum Insight segments. Despite these factors, Hynes opines that UnitedHealth Group Incorporated (NYSE:UNH)'s scale, market position, and diversified business are the key strengths, and believes that the stock's valuation is attractive. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH)'s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion. This was aided by growth in UnitedHealthcare and Optum. Notably, the Q2 2025 consolidated medical care ratio stood at 89.4%, reflecting an increase of 430 bps YoY. This was mainly because of medical cost trends, which significantly surpassed pricing trends, such as both unit costs and the intensity of services delivered, and the ongoing impacts of Medicare funding reductions. Hotchkis & Wiley, an investment management company, released its Q2 2025 investor letter and mentioned UnitedHealth Group Incorporated (NYSE:UNH). Here is what the fund said: 'UnitedHealth Group Incorporated (NYSE:UNH) is a large US health insurer. Until very recently, UNH traded at a material premium to its peers, reflecting its status as a premium growth stock with momentum. We did not own the stock. However, recent negative headlines, combined with the first earnings miss in 10 years, resulted in a >50% selloff in the company's shares. This decline contributed positively to the strategy's relative performance vs. the index, where UNH was a meaningful weight. We purchased UNH shares after the selloff at what we believe is a compelling valuation.' While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store